Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CHTR vs GSK✓SelectedUSD · GSKCHTR vs GSK performance historyLatest closeAs of-4.32%11/19
Stock and ETF performance explorer

CHTR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-80.5%
GSK return
+39.6%
Excess return
-120.0%
Maximum drawdown
-85.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.3%-1.6%-2.8%-3.9%
7D+0.4%-4.7%+5.1%+1.6%
30D+21.0%-4.7%+25.7%+22.4%
3M-12.7%-8.8%-3.9%-10.7%
6M-6.5%-4.6%-1.9%-5.5%
YTD-36.2%+1.0%-37.2%-36.0%
1Y-31.4%+6.9%-38.3%-31.8%
3Y-67.3%+52.5%-119.9%-69.8%
5Y-80.5%+40.3%-120.8%-81.6%
All-80.5%+39.6%-120.0%-81.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling